InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the complete record of transactions filed by DeHaan-Fullerton Karen. Director active across 1 company, notably Zomedica Corp.. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. History available since 19 May 2025. The latest transaction was disclosed on 19 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration